XML 33 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND INTANGIBLE ASSETS
12 Months Ended
Sep. 28, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS
GOODWILL AND INTANGIBLE ASSETS
The following table reflects goodwill by reportable operating segment:
(In millions)
Medical
 
Industrial
 
Total
Balance at September 29, 2017
$
146.9

 
$
95.0

 
$
241.9

Business combination

 
1.5

 
1.5

Settlement of post-close working capital adjustment
0.1

 
0.1

 
0.2

Balance at September 28, 2018
$
147.0

 
$
96.6

 
$
243.6


The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets:
(In millions)
September 28, 2018
 
September 29, 2017
Acquired existing technology
$
57.9

 
$
57.0

Patents, licenses and other
9.9

 
19.4

Customer contracts and supplier relationship
42.6

 
42.1

Accumulated amortization
(40.6
)
 
(31.2
)
Total intangible assets with finite lives
69.8

 
87.3

In-process research and development with indefinite lives
4.0

 
4.0

Total intangible assets
$
73.8

 
$
91.3

 
 
 
 

Amortization expense for intangible assets was $16.2 million, $10.5 million and $5.5 million in fiscal years 2018, 2017 and 2016, respectively.
As of September 28, 2018, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
 
Fiscal years:
 
2019
$
14.6

2020
14.2

2021
13.0

2022
11.4

2023
10.3

Thereafter
6.3

Total
$
69.8